Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John Swanson

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletionJonathan P Pearl, Jeremy Parris, Douglas A Hale, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Functionally significant renal allograft rejection is defined by transcriptional criteriaSteven C Hoffmann, Douglas A Hale, David E Kleiner, et al.
Transplantation|July 17, 2003
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)Allan D Kirk, Douglas A Hale, Roslyn B Mannon, et al.
Transplantation|October 24, 2002
Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injurySteven C Hoffmann, Robert L Kampen, Shashi Amur, et al.
Transplantation|November 27, 2002
Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantationSean P Montgomery, He Xu, Douglas K Tadaki, et al.
Clinical Transplants|April 12, 2007
Solid organ transplantation at the National Institutes of Health: development of a research-based transplantation practiceAllan D Kirk, Douglas A Hale, Elizabeth Ford, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletionJonathan P Pearl, Jeremy Parris, Douglas A Hale, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Functionally significant renal allograft rejection is defined by transcriptional criteriaSteven C Hoffmann, Douglas A Hale, David E Kleiner, et al.
Transplantation|July 17, 2003
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)Allan D Kirk, Douglas A Hale, Roslyn B Mannon, et al.
Transplantation|October 24, 2002
Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injurySteven C Hoffmann, Robert L Kampen, Shashi Amur, et al.
Transplantation|November 27, 2002
Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantationSean P Montgomery, He Xu, Douglas K Tadaki, et al.
Clinical Transplants|April 12, 2007
Solid organ transplantation at the National Institutes of Health: development of a research-based transplantation practiceAllan D Kirk, Douglas A Hale, Elizabeth Ford, et al.
Pageof 3